BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tawalbeh SM, Marin W, Morgan GA, Dang UJ, Hathout Y, Pachman LM. Serum protein biomarkers for juvenile dermatomyositis: a pilot study. BMC Rheumatol 2020;4:52. [PMID: 33015544 DOI: 10.1186/s41927-020-00150-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 McLellan K, Papadopoulou C. Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis. Curr Rheumatol Rep 2022. [PMID: 35680774 DOI: 10.1007/s11926-022-01076-4] [Reference Citation Analysis]
2 De Paepe B, Bracke KR, De Bleecker JL. An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis. Cytokine X 2022;4:100063. [PMID: 35128380 DOI: 10.1016/j.cytox.2022.100063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sato H, Inoue Y, Kawashima Y, Nakajima D, Ishikawa M, Konno R, Nakamura R, Kato D, Mitsunaga K, Yamamoto T, Yamaide A, Tomiita M, Hoshioka A, Ohara O, Shimojo N. In-Depth Serum Proteomics by DIA-MS with In Silico Spectral Libraries Reveals Dynamics during the Active Phase of Systemic Juvenile Idiopathic Arthritis. ACS Omega 2022;7:7012-23. [PMID: 35252692 DOI: 10.1021/acsomega.1c06681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 De Paepe B. Growth differentiation factor-15 as an emerging biomarker for identifying myositis. Expert Rev Clin Immunol 2022;:1-9. [PMID: 35023440 DOI: 10.1080/1744666X.2022.2021879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Roberson EDO, Mesa RA, Morgan GA, Cao L, Marin W, Pachman LM. Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive. Sci Rep 2022;12:275. [PMID: 34997119 DOI: 10.1038/s41598-021-04302-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ogundele M, Zhang JS, Goswami MV, Barbieri ML, Dang UJ, Novak JS, Hoffman EP, Nagaraju K, Cinrg-Dnhs Investigators, Hathout Y. Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy. Life (Basel) 2021;11:827. [PMID: 34440571 DOI: 10.3390/life11080827] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wang A, Morgan GA, Paller AS, Pachman LM. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis. J Am Acad Dermatol 2021;84:1610-8. [PMID: 33359787 DOI: 10.1016/j.jaad.2020.12.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]